v3.25.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]        
Net product sales $ 154,688 $ 126,669 $ 279,937 $ 237,072
Cost of goods sold 15,217 11,261 26,915 24,828
Gross profit 139,471 115,408 253,022 212,244
Operating expenses:        
Research and development 60,848 24,683 88,687 53,012
Selling, general, and administrative 84,543 73,576 176,370 161,605
Restructuring charges 0 0 0 6,045
Loss on impairment of assets 1,702 0 1,702 0
Depreciation and amortization 1,852 2,182 3,689 4,336
Total operating expenses 148,945 100,441 270,448 224,998
Loss from operations (9,474) 14,967 (17,426) (12,754)
Other expense:        
Interest income 843 1,370 1,655 2,910
Interest expense (11,565) (12,512) (23,020) (24,948)
Other income (expense) 1,015 (3,717) 1,565 (8,683)
Loss before income tax (19,181) 108 (37,226) (43,475)
Income tax expense (5,239) (15,805) (8,880) (20,641)
Net loss attributable to common stockholders $ (24,420) $ (15,697) $ (46,106) $ (64,116)
Net loss attributable to common stockholders per common share - basic (in dollars per share) $ (0.08) $ (0.05) $ (0.15) $ (0.21)
Net loss attributable to common stockholders per common share — diluted (in dollars per share) $ (0.08) $ (0.05) $ (0.15) $ (0.21)
Weighted average common shares outstanding - basic (in shares) 308,254,256 303,773,922 307,972,054 303,336,787
Weighted average common shares outstanding - diluted (in shares) 308,254,256 303,773,922 307,972,054 303,336,787